BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Zhao P, Yang L, Li Y, Tian Y, Li S. System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling. Sci Rep 2016;6:25492. [PMID: 27146975 DOI: 10.1038/srep25492] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Guan Q, Zhao P, Tian Y, Yang L, Zhang Z, Li J. Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes. Annals of Medicine 2022;54:2309-20. [DOI: 10.1080/07853890.2022.2112070] [Reference Citation Analysis]
2 Jin F, Zhang L, Chen K, Miao Y, Liu Y, Tian Y, Li J, Carbone F. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-κB Signaling. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/3360771] [Reference Citation Analysis]
3 Li J, Zhao P, Tian Y, Li K, Zhang L, Guan Q, Mei X, Qin Y. The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD. Front Pharmacol 2021;12:709702. [PMID: 34776947 DOI: 10.3389/fphar.2021.709702] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Wang T, Liang L, Zhao C, Sun J, Wang H, Wang W, Lin J, Hu Y. Elucidating direct kinase targets of compound Danshen dropping pills employing archived data and prediction models. Sci Rep 2021;11:9541. [PMID: 33953309 DOI: 10.1038/s41598-021-89035-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Liu Y, Huang K, Wang Y, Hu E, Wei B, Song Z, Zou Y, Ge L, Chen L, Li W. Integration of SNP Disease Association, eQTL, and Enrichment Analyses to Identify Risk SNPs and Susceptibility Genes in Chronic Obstructive Pulmonary Disease. Biomed Res Int 2020;2020:3854196. [PMID: 33457407 DOI: 10.1155/2020/3854196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wang Y, Tan J, Hu P, Pei Q, Wen Y, Ma W, Shi K, Li Z, Li H, Cheng F, Gu X, Yao X, Man Y, Zhao R, Feng S, Ding X, Yang T. Traditional Chinese medicine compound, Bu Sheng Hui Yang Fang, promotes the proliferation of lymphocytes in the immunosuppressed mice potentially by upregulating IL-4 signaling. Biomed Pharmacother 2021;134:111107. [PMID: 33341059 DOI: 10.1016/j.biopha.2020.111107] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Mohammadtursun N, Li Q, Abuduwaki M, Jiang S, Zhang H, Sun J, Dong J. Loki zupa alleviates inflammatory and fibrotic responses in cigarette smoke induced rat model of chronic obstructive pulmonary disease. Chin Med 2020;15:92. [PMID: 32874197 DOI: 10.1186/s13020-020-00373-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhao P, Liu X, Dong H, Tian Y, Feng S, Zhao D, Ren Z, Zhang L, Li J. Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor. Front Pharmacol 2020;11:1212. [PMID: 32848801 DOI: 10.3389/fphar.2020.01212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Li JS, Liu XF, Dong HR, Zheng WC, Feng SX, Tian YG, Zhao P, Ma JD, Ren ZX, Xie Y. Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease. J Integr Med 2020;18:351-62. [PMID: 32565294 DOI: 10.1016/j.joim.2020.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ran N, Pang Z, Gu Y, Pan H, Zuo X, Guan X, Yuan Y, Wang Z, Guo Y, Cui Z, Wang F. An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease. Metabolites 2019;9:E111. [PMID: 31185592 DOI: 10.3390/metabo9060111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
11 Ma J, Tian Y, Li J, Zhang L, Wu M, Zhu L, Liu S. Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling. Evid Based Complement Alternat Med 2019;2019:6708645. [PMID: 31275415 DOI: 10.1155/2019/6708645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vitenberga Z, Pilmane M, Babjoniševa A. The evaluation of inflammatory, anti-inflammatory and regulatory factors contributing to the pathogenesis of COPD in airways. Pathol Res Pract 2019;215:97-105. [PMID: 30392917 DOI: 10.1016/j.prp.2018.10.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Xin T, Zhang Y, Pu X, Gao R, Xu Z, Song J. Trends in herbgenomics. Sci China Life Sci 2019;62:288-308. [PMID: 30128965 DOI: 10.1007/s11427-018-9352-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
14 Zhao P, Li J, Tian Y, Mao J, Liu X, Feng S, Li J, Bian Q, Ji H, Zhang L. Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula. Journal of Ethnopharmacology 2018;217:152-62. [DOI: 10.1016/j.jep.2018.02.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
15 Li M, Li Y, Li J, Zhao P, Bai Y, Feng S, Liu X, Wang Y, Bian Q, Li J. Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling. Evid Based Complement Alternat Med 2017;2017:2089027. [PMID: 29387126 DOI: 10.1155/2017/2089027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
16 Zhao P, Li J, Li Y, Tian Y, Yang L, Li S. Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD. Biomed Res Int 2017;2017:7091087. [PMID: 28424787 DOI: 10.1155/2017/7091087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lu S, Han Y, Chu H, Kong L, Zhang A, Yan G, Sun H, Wang P, Wang X. Characterizing serum metabolic alterations of Alzheimer's disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Food Funct 2017;8:1660-71. [DOI: 10.1039/c7fo00154a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]